![James Kinley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Kinley
Financieel Directeur/CFO bij
GREY MATTERS HEALTH INC.
Vermogen: 95 004 $ op 31-05-2026
Profiel
James F.
Kinley is currently Independent Director at Medicure, Inc. since 2022, Independent Director at Waverley Pharma, Inc. since 2024, Chief Financial Officer at Cytophage Technologies Ltd. starting 2026, Chief Financial Officer & Secretary at Grey Matters Health, Inc. since 2022, and Chief Financial Officer at Algernon Neuroscience, Inc. Formerly, Mr. Kinley was Principal at Ernst & Young LLP, Chief Financial Officer at Medicure, Inc. from 2011 to 2021, Manager at Manitoba Telecom Services, Inc., and Chief Financial Officer at Luminor Medical Technologies, Inc. from 2011 to 2016.
Education includes undergraduate studies at Asper School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 27-12-2025 | 178.992 ( 3,3% ) | 56 740 $ | 31-05-2026 | |
MEDICURE INC. 0,45% | 02-04-2026 | 47.100 ( 0,45% ) | 37 868 $ | 31-05-2026 |
| 05-05-2025 | 56.500 ( 0,1% ) | 396 $ | 31-05-2026 |
Actieve functies van James Kinley
| Bedrijven | Functie | Begin |
|---|---|---|
| GREY MATTERS HEALTH INC. | Financieel Directeur/CFO | 01-12-2021 |
| MEDICURE INC. | Directeur/Bestuurslid | 16-06-2022 |
| WAVERLEY PHARMA INC. | Directeur/Bestuurslid | 20-06-2024 |
| CYTOPHAGE TECHNOLOGIES LTD. | Financieel Directeur/CFO | 20-01-2026 |
Algernon Neuroscience, Inc. | Financieel Directeur/CFO | - |
Eerdere bekende functies van James Kinley
| Bedrijven | Functie | Einde |
|---|---|---|
| MEDICURE INC. | Financieel Directeur/CFO | 15-05-2021 |
Luminor Medical Technologies, Inc.
 Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and development services | Financieel Directeur/CFO | 18-01-2016 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | - |
| BELL MTS | Corporate Officer/Principal | - |
Opleiding van James Kinley
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
24
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Medicure, Inc.
 Medicure, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research, development and commercialization & marketing of human therapeutics products | Health Technology |
Manitoba Telecom Services, Inc.
 Manitoba Telecom Services, Inc. Wireless TelecommunicationsCommunications Provides telecommunications services | Communications |
Luminor Medical Technologies, Inc.
Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and development services | Commercial Services |
Asper School of Business
 Asper School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Algernon Pharmaceuticals, Inc.
 Algernon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage, drug development and repurposing company | Health Technology |
Waverley Pharma, Inc.
 Waverley Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Algernon Neuroscience, Inc. | |
Cytophage Technologies Ltd.
 Cytophage Technologies Ltd. Financial ConglomeratesFinance Produces bacteriophages for bacterial infections and diseases | Finance |
